Microsoft moves Novo Nordisk research agent to Foundry-managed infrastructure

Microsoft says a joint team with Novo Nordisk moved an agent for secondary analysis of clinical trial data to hosted infrastructure in Microsoft Foundry. The agent interprets research questions, writes and executes analysis code, and returns summaries and visualizations. The migration transfers session compute, state persistence, scaling and lifecycle management to Foundry while the team retains control of agent logic, models and tools. Each session receives a separate virtual-machine sandbox. The team kept existing backend interfaces and evaluation graders to check for regressions. It remains responsible for access controls, telemetry protection and reviewing systems the agent can call.